Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W D Figg

Showing results (71-80 of 135) with videos related to

Pageof 14
Sort By:
Urologia Internationalis|December 11, 1999
A phase II trial of gallium nitrate in patients with androgen-metastatic prostate cancerA M Senderowicz, R Reid, D Headlee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1996
A phase I study of pentosan polysulfate sodium in patients with advanced malignanciesR M Lush, W D Figg, J M Pluda, et al.
Antimicrobial Agents and Chemotherapy|September 26, 1997
Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasisT J Walsh, P Whitcomb, S Piscitelli, et al.
The Prostate|September 1, 1996
The differentiating agent phenylacetate increases prostate-specific antigen production by prostate cancer cellsR Walls, A Thibault, L Liu, et al.
Journal of Pharmaceutical Sciences|January 6, 1999
Pharmacokinetics of thalidomide in an elderly prostate cancer populationW D Figg, S Raje, K S Bauer, et al.
Leukemia|October 6, 2001
The Hsp90 inhibitor geldanamycin selectively sensitizes Bcr-Abl-expressing leukemia cells to cytotoxic chemotherapyM V Blagosklonny, T Fojo, K N Bhalla, et al.
Cancer|September 18, 1998
A phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosisD L Bartlett, J F Buell, S K Libutti, et al.
The Cancer Journal From Scientific American|May 1, 1997
Continuous hyperthermic peritoneal perfusion with cisplatin for the treatment of peritoneal mesotheliomaG Y Ma, D L Bartlett, E Reed, et al.
Journal of the National Cancer Institute|February 2, 1994
Surprising activity of flutamide withdrawal, when combined with aminoglutethimide, in treatment of "hormone-refractory" prostate cancerO Sartor, M Cooper, M Weinberger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Pharmacologic variables associated with the development of neurologic toxicity in patients treated with suraminR J Bitton, W D Figg, D J Venzon, et al.
Pageof 14

Showing results (71-80 of 135) with videos related to

Sort By:
Pageof 14
Urologia Internationalis|December 11, 1999
A phase II trial of gallium nitrate in patients with androgen-metastatic prostate cancerA M Senderowicz, R Reid, D Headlee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1996
A phase I study of pentosan polysulfate sodium in patients with advanced malignanciesR M Lush, W D Figg, J M Pluda, et al.
Antimicrobial Agents and Chemotherapy|September 26, 1997
Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasisT J Walsh, P Whitcomb, S Piscitelli, et al.
The Prostate|September 1, 1996
The differentiating agent phenylacetate increases prostate-specific antigen production by prostate cancer cellsR Walls, A Thibault, L Liu, et al.
Journal of Pharmaceutical Sciences|January 6, 1999
Pharmacokinetics of thalidomide in an elderly prostate cancer populationW D Figg, S Raje, K S Bauer, et al.
Leukemia|October 6, 2001
The Hsp90 inhibitor geldanamycin selectively sensitizes Bcr-Abl-expressing leukemia cells to cytotoxic chemotherapyM V Blagosklonny, T Fojo, K N Bhalla, et al.
Cancer|September 18, 1998
A phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosisD L Bartlett, J F Buell, S K Libutti, et al.
The Cancer Journal From Scientific American|May 1, 1997
Continuous hyperthermic peritoneal perfusion with cisplatin for the treatment of peritoneal mesotheliomaG Y Ma, D L Bartlett, E Reed, et al.
Journal of the National Cancer Institute|February 2, 1994
Surprising activity of flutamide withdrawal, when combined with aminoglutethimide, in treatment of "hormone-refractory" prostate cancerO Sartor, M Cooper, M Weinberger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Pharmacologic variables associated with the development of neurologic toxicity in patients treated with suraminR J Bitton, W D Figg, D J Venzon, et al.
Pageof 14